Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Anemia, Refractory, with Excess of Blasts 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 48fludarabine phosphate 45fludarabine 38Whole-Body Irradiation 38Mycophenolic Acid 37Imatinib Mesylate 36nilotinib 34Tacrolimus 30Busulfan 23Cyclosporine 18Melphalan 17Granulocyte Colony-Stimulating Factor 17Dasatinib 17thymoglobulin 16Methotrexate 16Thiotepa 15Peripheral Blood Stem Cell Transplantation 15Antilymphocyte Serum 15bosutinib 13Filgrastim 13Stem Cell Transplantation 11sargramostim 8ponatinib 8Cytarabine 8Cyclosporins 8Cord Blood Stem Cell Transplantation 8Clofarabine 8Sirolimus 7Rituximab 7plerixafor 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Parathyroid Hormone × Clear all
NCT00393380 2013-04-29

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor

The Emmes Company, LLC

Phase 2 Terminated
13 enrolled 14 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡